tiprankstipranks
Instil Bio initiated with a Market Perform at JMP Securities
PremiumThe FlyInstil Bio initiated with a Market Perform at JMP Securities
2M ago
Baird positive on Instil Bio’s SYN-2510 development strategy
Premium
The Fly
Baird positive on Instil Bio’s SYN-2510 development strategy
3M ago
Instil Bio Outlines Oncology Strategy and Collaborative Efforts
Premium
Company Announcements
Instil Bio Outlines Oncology Strategy and Collaborative Efforts
3M ago
Instil Bio price target raised to $25 from $18 at H.C. Wainwright
PremiumThe FlyInstil Bio price target raised to $25 from $18 at H.C. Wainwright
4M ago
Instil Bio Presents Latest Updates with Investor Disclaimer
Premium
Company Announcements
Instil Bio Presents Latest Updates with Investor Disclaimer
4M ago
Instil Bio reports Q2 EPS ($2.29), two estimates ($2.98)
Premium
The Fly
Instil Bio reports Q2 EPS ($2.29), two estimates ($2.98)
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100